irinotecanUGT1A1pancreatic cancercolorectal cancerCRCPC
…etabolizers is not affected by an upfront 30% dose reduction of irinotecan. Therefore, UGT1A1 genotype-guided dosing of irinotecan can be …
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: UGT1A1 ×
UGT1A1
This drug is selected. Its supporting articles are shown below.